Your browser doesn't support javascript.
loading
Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis.
Hashmi, Shahrukh; Ahmed, Mohammad; Murad, M Hassan; Litzow, Mark R; Adams, Roberta H; Ball, Lynne M; Prasad, Vinod K; Kebriaei, Partow; Ringden, Olle.
Afiliação
  • Hashmi S; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: Hashmi.shahrukh@mayo.edu.
  • Ahmed M; Department of Internal Medicine, Providence Hospital, Washington, DC, USA.
  • Murad MH; Robert D and Patricia E Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
  • Litzow MR; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Adams RH; Department of Pediatrics, Phoenix Children's Hospital, Phoenix, AZ, USA.
  • Ball LM; Department of Pediatrics, LUMC, Leiden, Netherlands.
  • Prasad VK; Department of Pediatrics, Duke University, Durham, NC, USA.
  • Kebriaei P; Department of Stem Cell Transplant, M D Anderson Cancer Center, Houston, TX, USA.
  • Ringden O; Department of Laboratory Medicine, Karolinska Institute, Solna, Sweden.
Lancet Haematol ; 3(1): e45-52, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26765648

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Mesenquimais / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Mesenquimais / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article